Seven
-
School of Medicine Basic Science’s Monteggia and Tyska named fellows by the American Association for the Advancement of Science
Lisa M. Monteggia and Matthew J. Tyska are among the 471 scientists elected as 2024 fellows of the American Association for the Advancement of Science. Dean John Kuriyan was also recently elected a member of the 2025 class of fellows of the American Association for Cancer Research academy. Read MoreMar. 27, 2025
-
Vanderbilt establishes open access publishing agreement for ‘Nature’ and other leading science journals
“This transformative agreement allows Vanderbilt researchers to benefit from Nature’s tremendous influence and reach,” University Librarian Jon Shaw said. “Our research findings will reach global audiences immediately upon publication, speeding up scientific innovation and progress. This collaboration not only strengthens Vanderbilt’s reputation but will aid in attracting top faculty, students and partnerships to the university.” Read MoreMar. 10, 2025
-
JAMA Network and Heard Libraries establish read-and-publish pilot agreement, broadening access to health sciences research
Vanderbilt-affiliated authors may publish their original research articles APC-free in JAMA Network journals through a Creative Commons license. Twelve of the network’s journals—including JAMA Internal Medicine, JAMA Neurology and JAMA Oncology—are ranked in the top quartile of their respective subject areas. Read MoreFeb. 27, 2025
-
Carrie Jones wins Wellcome Trust Discovery Award to combat opioid misuse and addiction
Great Britain’s Wellcome Trust has recognized Vanderbilt’s Carrie K. Jones and the University of Glasgow’s Andrew Tobin with their prestigious Discovery Award. The pair will study how blocking the M5 muscarinic receptor in the brain counteracts opioids’ addictive properties, which could lead to new treatments for preventing or addressing opioid addiction. Read MoreFeb. 10, 2025
-
Warren Center for Neuroscience Drug Discovery researchers create new compound to potentially treat negative and positive symptoms of schizophrenia
Researchers from the Warren Center for Neuroscience Drug Discovery, in collaboration with Boehringer Ingelheim, developed a compound that can treat both negative and positive symptoms of schizophrenia in rodents. The compound holds promise as an investigational tool and an inspiration for novel schizophrenia therapies. Read MoreJan. 16, 2025
-
Mary Ann Liebert, Inc. and Heard Libraries establish read-and-publish agreement in support of open science
A new open access agreement between Mary Ann Liebert, Inc. and the Heard Libraries—the first of its kind that a North American institution has signed with the publisher—expands opportunities for Vanderbilt authors to publish their research in leading science journals. Mary Ann Liebert, Inc. publishes of more than 100 peer-reviewed academic journals. Read MoreNov. 21, 2024
-
Ken Lau and Eunyoung Choi named 2024 Stanley Cohen Innovation Fund awardees
Eunyoung Choi and Ken Lau receive funding for novel cancer research, which may ultimately result in cancer detection and treatment options for patients. The fund supports early-stage, high-risk high-reward research projects and honor Cohen’s seminal discoveries, which led to the invention of many anticancer drugs used today. Read MoreNov. 21, 2024
-
Leigh Anne Tang wins 2024 Brighter Ventures Award
Leigh Anne Tang won the 2024 Brighter Ventures Award for her efforts to leverage health care artificial intelligence to influence the overdose crisis. She is the first Ph.D. student at Vanderbilt to work with the state on this type of translational research. Read MoreNov. 21, 2024
-
Vanderbilt building molecular atlas of colorectal cancer across different stages of disease onset with $5 million National Cancer Institute grant
Colorectal cancer is the second leading cause of cancer-related deaths in the U.S. Ken Lau and Jeffrey Spraggins are creating the first spatially mapped atlas characterizing the progression trajectories of early-onset colorectal cancer versus average-onset CRC as they transition from precancerous lesions to malignant cancers. Read MoreNov. 20, 2024
-
Center for Extracellular Vesicle Research hosts annual retreat
The Center for Extracellular Vesicle Research, which is made up of over 20 laboratories spanning Vanderbilt University, held its annual retreat in late September. Researchers discussed the types of biomolecular cargoes EVs contain and how EVs holding unique cargoes can be used as diagnostic tools. Read MoreNov. 19, 2024